ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2024

Zinzino group revenue increased with a total of 15%, compared with the previous year.

GOTHENBURG, Sweden, Feb. 5, 2024 /PRNewswire/ — The revenue in January for Zinzino’s sales markets increased by 17% and amounted to SEK 140.2 (120.3) million. Faun Pharma’s external sales decreased by 11% and amounted to SEK 8.1 (9.1) million. Overall, the Group increased revenues by 15% to SEK 148.3 (129.4) million compared with the previous year.

Revenues were distributed as follows:

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
–Central Europe: Austria, Germany, Switzerland
–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
–North America: Canada, USA, Mexico
–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
–Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge: [email protected]

Certified Adviser: Carnegie Investment Bank AB (publ)

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-january-2024-302053390.html